Merck & CompanyvsPennant

MRK and PNTG stock compared: price, dividend, valuation and results, from SEC filings.

MRK

Merck & Company, Inc.

$137.78

Value $341B

-3.90%
MRK's page

PNTG

The Pennant Group, Inc.

$35.81

Value $1.2B

-1.89%
PNTG's page

Merck & Company (MRK) has a market value of $341B and Pennant (PNTG) $1.2B. Over the last year, with dividends, MRK moved +52.7% and PNTG +41.0%. The P/E is 138.9 for MRK and 34.6 for PNTG. Dividend yield: MRK 2.47%, PNTG none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    MRK$341B

    PNTG$1.2B

    MRK is 274 times PNTG

  • Revenue, 12 months

    MRK$67.4B

    PNTG$1.2B

    MRK is 57 times PNTG

  • Net income, 12 months

    MRK$2.5B

    PNTG$36M

    MRK is 68 times PNTG

  • Operating margin

    MRK–

    PNTG5.8%

  • ROIC

    MRK3.9%

    PNTG9.4%

    5.5 points apart

  • P/E

    MRK138.9

    PNTG34.6

    MRK is 4.0 times PNTG

  • Dividend yield

    MRK2.5%

    PNTG0.0%

    2.5 points apart

  • 5-year return

    MRK+94.3%

    PNTG+47.1%

    47.2 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

MRK+94.3%

PNTG+47.1%

5010015020020222023202420252026
Returns by period
PeriodMRKWith dividendsPNTGWith dividends
1 year since November 17, 2025+52.7%Price +48.4%+41.0%Price +41.0%
3 years since November 17, 2023+48.4%+14.1% a yearPrice +35.4%+172.3%+39.6% a yearPrice +172.3%
5 years since November 17, 2021+94.3%+14.2% a yearPrice +66.8%+47.1%+8.0% a yearPrice +47.1%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

MRKMerck & CompanyPNTGPennant

Valuation

MRKPNTG
Valuation
Price$137.78$35.81
Market value$341B$1.2B
Enterprise value (EV)$385B$1.4B
P/E138.934.6
P/E, 5-year median14.835.7
P/B7.63.0
EV/EBIT80.820.9
Free cash flow yield4.3%2.8%

Results and growth

MRKPNTG
Results and growth
Revenue, 12 months$67.4B$1.2B
Net income, 12 months$2.5B$36M
Free cash flow, 12 months$14.7B$34M
Earnings per share, 12 months$0.98$1.00
Revenue growth, year on year1.3%36.3%
Revenue growth a year, past+9.4%over 5 years+19.4%over 5 years
EPS growth a year, past+21.2%over 5 years+10.1%over 5 years

Margins and returns on capital

MRKPNTG
Margins and returns on capital
Gross margin71.8%18.3%
Operating margin–5.8%
Net margin3.6%3.1%
ROIC3.9%9.4%
ROE5.2%9.3%

Balance sheet

MRKPNTG
Balance sheet
Cash$9.7B$18M
Total debt$53.8B$489M
Net debt / EBITDA5.72.4
Interest cover2.4×5.2×

Dividends and buybacks

MRKPNTG
Dividends and buybacks
Dividend yield2.5%–
Dividend per share, 12 months$3.40–
Dividend growth a year, past+5.8%over 5 years–
Buyback yield1.5%–
Shareholder yield4.0%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: MRK or PNTG

Didn't find what you were looking for?

Ask us
Which is bigger, Merck & Company or Pennant?

By market value, Merck & Company ($341B) is about 274.4 times Pennant ($1.2B), at today's prices.

How did MRK and PNTG stock do over the last 5 years?

Since November 17, 2021, MRK's price moved +66.8% and PNTG's +47.1%. With dividends: MRK +94.3% (+14.2% a year), PNTG +47.1% (+8.0% a year). Past returns do not predict future ones.

Which pays the higher dividend, MRK or PNTG?

The dividend yield at today's price is 2.47% for Merck & Company and none for Pennant. Over the last twelve months they paid $3.40 and – per share.

What is the P/E of MRK and PNTG?

At today's price, the P/E is 138.9 for MRK and 34.6 for PNTG. The median of the last five years was 14.8 and 35.7, which shows where each stands against its own past.

Which has the higher profit margins, Merck & Company or Pennant?

Over the last twelve months, the net margin was 3.6% for Merck & Company and 3.1% for Pennant, and the operating margin – and 5.8%. Revenue was $67.4B and $1.2B.

Which is the better investment, Merck & Company or Pennant?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.